Pembrolizumab as a Treatment for Esophageal Squamous Cell Carcinoma
According to a story from the ASCO Post, the US Food and Drug Administration (FDA) first approved the drug pembrolizumab as a treatment for advanced esophageal squamous cell carcinoma on…